1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow BTLA protein, human: new trials by email Literature Review of BTLA protein, human trials Research Report on BTLA protein, human
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors JS004, a recombinant humanized, IgG4κ monoclonal antibody (mAb) specific to B- and T-lymphocyte attenuator (BTLA); Toripalimab Injection - Melanoma, Renal Carcinoma | Phase 1 | Completed | Shanghai Junshi Bioscience Co., Ltd. | 47 | 2021-04-12 | 2026-07-08 |
Carcinoma, Renal Cell (1) · Carcinoma, Transitional Cell (1) · Melanoma (1)
Shanghai Junshi Bioscience Co., Ltd. (1)
China (1)
Jun Guo (1)